Hematology

Filter

Innovating in β-Thalassemia Care

August 2025

At the European Hematology Association (EHA) 2025 annual meeting in Milan, Italy, experts Maria Domenica Cappellini, Sujit Sheth…

Dr Keith Stewart chairs a discussion on tumour biology-guided treatment for multiple myeloma

At the Myeloma 2015 meeting, Dr Keith Stewart (Mayo Clinic, Scottsdale, AZ) chairs a discussion with Prof Gareth Morgan (University of Arkansas…

Clinical significance of progenitor cells in multiple myeloma

Prof Kenneth Anderson (Harvard Medical School, Boston, MA) chairs a discussion with Prof Leif Bergsagel (Mayo Clinic, Scottsdale, AZ) and Prof Gareth…

Prof John Gribben and Prof Andre Goy at ASH 2014: Treating mantle cell lymphoma (Part 3)

Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Andre Goy (John Theurer Cancer Center, Hackensack, NJ) at the 2014 American Society…

ASH 2014: Recent investigational advances in mantle cell lymphoma treatment

Prof Simon Rule (Derriford Hospital, Plymouth, UK) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses recent advances in the…

EMJ

ASH 2014: Phase II study of lenalidomide plus rituximab for mantle cell lymphoma (Part 2)

Dr Jia Ruan (Weill Cornell Medical College, New York, NY) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses the clinical relevance…

EMJ

Prof John Gribben and Prof Marek Trněný at ASH 2014: Mantle cell lymphoma advances (Part 1)

At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof John Gribben (Barts Cancer Institute, London, UK) and Prof Marek Trněný (Charles…

EMJ

ASH 2014: New therapies for mantle cell lymphoma

Prof Umberto Vitolo (Città della Salute e della Scienza di Torino, Turin, Italy) at the 2014 American Society of Hematology (ASH) Annual Meeting…

Loading posts...

« Previous 1 … 7 8 9